Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Li Wan Po

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Emerging Infectious Diseases|October 29, 2009
Maximizing the value of drug stockpiles for pandemic influenzaAlain Li Wan Po, Peter Farndon, Nick Palmer
European Journal of Clinical Pharmacology|January 30, 2010
Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-exampleAlain Li-Wan-Po, Peter Farndon, Charles Craddock, et al.
British Journal of Clinical Pharmacology|February 1, 2011
Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicineAlain Li-Wan-Po, Bart Loeys, Peter Farndon, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17Alain Li-Wan-Po, Thierry Girard, Peter Farndon, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Extracting numerical data from published reports of pharmacokinetics investigations: method description and validationIrismar Reis de Oliveira, Rogério Santos-Jesus, Alain Li Wan Po, et al.
The Annals of Pharmacotherapy|February 10, 2011
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case ExampleAlain Li-Wan-Po, Peter A Farndon, Susumu Kobayashi, et al.
Pharmacogenetics and Genomics|November 6, 2009
A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermiaHans F Ginz, Henrik Rüffert, Soledad Levano, et al.
Lancet (London, England)|December 22, 2004
Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trialMara Ozolins, E Anne Eady, Anthony J Avery, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Emerging Infectious Diseases|October 29, 2009
Maximizing the value of drug stockpiles for pandemic influenzaAlain Li Wan Po, Peter Farndon, Nick Palmer
European Journal of Clinical Pharmacology|January 30, 2010
Integrating pharmacogenetics and therapeutic drug monitoring: optimal dosing of imatinib as a case-exampleAlain Li-Wan-Po, Peter Farndon, Charles Craddock, et al.
British Journal of Clinical Pharmacology|February 1, 2011
Preventing the aortic complications of Marfan syndrome: a case-example of translational genomic medicineAlain Li-Wan-Po, Bart Loeys, Peter Farndon, et al.
British Journal of Clinical Pharmacology|March 18, 2010
Pharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17Alain Li-Wan-Po, Thierry Girard, Peter Farndon, et al.
Fundamental & Clinical Pharmacology|August 14, 2003
Extracting numerical data from published reports of pharmacokinetics investigations: method description and validationIrismar Reis de Oliveira, Rogério Santos-Jesus, Alain Li Wan Po, et al.
The Annals of Pharmacotherapy|February 10, 2011
The Pharmacogenetic Rescue of Side-Lined Anticancer Drugs to the Front-Line: Gefitinib as a Case ExampleAlain Li-Wan-Po, Peter A Farndon, Susumu Kobayashi, et al.
Pharmacogenetics and Genomics|November 6, 2009
A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermiaHans F Ginz, Henrik Rüffert, Soledad Levano, et al.
Lancet (London, England)|December 22, 2004
Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trialMara Ozolins, E Anne Eady, Anthony J Avery, et al.
Pageof 2